{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:30:12Z","timestamp":1787311812651,"version":"build-2736575974"},"reference-count":52,"publisher":"JLE","issue":"2","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Dermatol"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1684\/ejd.2019.3533","type":"journal-article","created":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T11:27:50Z","timestamp":1696850870000},"page":"115-120","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Fibrillar-type dermatitis herpetiformis"],"prefix":"10.1684","volume":"29","author":[{"given":"Teruhiko","family":"Makino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadamichi","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"18929","published-online":{"date-parts":[[2019,5,27]]},"reference":[{"key":"3533_CR1","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1016\/S0140-6736(66)91692-8","volume":"2","author":"J Marks","year":"1966","unstructured":"Marks J, Shuster S, Watson AJ. Small-bowel changes in dermatitis herpetiformis. Lancet 1966; 2: 1280\u20132.","journal-title":"Lancet"},{"key":"3533_CR2","doi-asserted-by":"publisher","first-page":"857","DOI":"10.7326\/0003-4819-93-6-857","volume":"93","author":"SI Katz","year":"1980","unstructured":"Katz SI, Hall RP, Lawley TJ, et al. Dermatitis herpetiformis: the skin and gut. Ann Intern Med 1980; 93: 857\u201374.","journal-title":"Ann Intern Med"},{"key":"3533_CR3","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/j.1365-2133.2011.10385.x","volume":"165","author":"TT Salmi","year":"2011","unstructured":"Salmi TT, Hervonen K, Kautiainen H, et al. Prevalence and incidence of dermatitis herpetiformis: a 40-year prospective study from Finland. Br J Dermatol 2011; 165: 354\u20139.","journal-title":"Br J Dermatol"},{"key":"3533_CR4","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/ajg.2014.55","volume":"109","author":"J West","year":"2014","unstructured":"West J, Fleming KM, Tata LJ, et al. Incidence and prevalence of celiac disease and dermatitis herpetiformis in the UK over two decades: population-based study. Am J Gastroenterol 2014; 109: 757\u201368.","journal-title":"Am J Gastroenterol"},{"key":"3533_CR5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1159\/000051808","volume":"204","author":"M Shibahara","year":"2002","unstructured":"Shibahara M, Nakano H, Shimizu M, et al. Dermatitis herpetiformis in Japan: an update. Dermatology 2002; 204: 37\u201342.","journal-title":"Dermatology"},{"key":"3533_CR6","doi-asserted-by":"publisher","first-page":"562168","DOI":"10.1155\/2012\/562168","volume":"2012","author":"C Ohata","year":"2012","unstructured":"Ohata C, Ishii N, Hamada T, et al. Distinct characteristics in Japanese dermatitis herpetiformis: a review of all 91 Japanese patients over the last 35 years. Clin Dev Immunol 2012; 2012: 562168.","journal-title":"Clin Dev Immunol"},{"key":"3533_CR7","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/bjd.13965","volume":"174","author":"C Ohata","year":"2016","unstructured":"Ohata C, Ishii N, Niizeki H, et al. Unique characteristics in Japanese dermatitis herpetiformis. Br J Dermatol 2016; 174: 180\u20133.","journal-title":"Br J Dermatol"},{"key":"3533_CR8","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1159\/000246522","volume":"191","author":"K Shimizu","year":"1995","unstructured":"Shimizu K, Hashimoto T, Fukuda T, et al. A Japanese case of the fibrillar type of dermatitis herpetiformis. Dermatology 1995; 191: 88\u201392.","journal-title":"Dermatology"},{"key":"3533_CR9","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1111\/j.1365-2133.2010.10153.x","volume":"164","author":"Y Asano","year":"2011","unstructured":"Asano Y, Makino T, Ishida W, et al. Detection of antibodies to epidermal transglutaminase but not tissue transglutaminase in Japanese patients with dermatitis herpetiformis. Br J Dermatol 2011; 164: 883\u20134.","journal-title":"Br J Dermatol"},{"key":"3533_CR10","doi-asserted-by":"publisher","first-page":"642","DOI":"10.2340\/00015555-2604","volume":"97","author":"T Makino","year":"2017","unstructured":"Makino T, Yoshihisa Y, Mizawa M, et al. Increased serum levels of Th2-type cytokines and eotaxin in fibrillar-type dermatitis herpetiformis. Acta Derm Venereol 2017; 97: 642\u20133.","journal-title":"Acta Derm Venereol"},{"key":"3533_CR11","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1365-2133.1978.tb07335.x","volume":"98","author":"T Reunala","year":"1978","unstructured":"Reunala T. Gluten-free diet in dermatitis herpetiformis. II. Morphological and immunological findings in the skin and small intestine of 12 patients and matched controls. Br J Dermatol 1978; 98: 69\u201378.","journal-title":"Br J Dermatol"},{"key":"3533_CR12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1136\/bmj.308.6920.13","volume":"308","author":"B Sigurgeirsson","year":"1994","unstructured":"Sigurgeirsson B, Agnarsson BA, Lindel\u00f6f B. Risk of lymphoma in patients with dermatitis herpetiformis. BMJ 1994; 308: 13\u20135.","journal-title":"BMJ"},{"key":"3533_CR13","first-page":"1209","volume":"26","author":"K Takada","year":"1984","unstructured":"Takada K, Fujigaki H, Uehara M. Dermatitis herpetiformis Duhring cured by tranilast. Hifuka-no-Rinsho 1984; 26: 1209\u201311 (Japanese).","journal-title":"Hifuka-no-Rinsho"},{"key":"3533_CR14","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1111\/j.1346-8138.2000.tb02222.x","volume":"27","author":"Y Amo","year":"2000","unstructured":"Amo Y, Tanei R, Tanabe K, et al. Dermatitis herpetiformis in a Japanese patient with anaplastic large cell lymphoma. J Dermatol 2000; 27: 533\u20136.","journal-title":"J Dermatol"},{"key":"3533_CR15","first-page":"1039","volume":"3","author":"K Tamaki","year":"1981","unstructured":"Tamaki K, Yaoita H. Dermatitis herpetiformis Duhring. Hifubyo Shinryo 1981; 3: 1039\u201342 (Japanese).","journal-title":"Hifubyo Shinryo"},{"key":"3533_CR16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1399-0039.1997.tb02706.x","volume":"49","author":"A Spurkland","year":"1997","unstructured":"Spurkland A, Ingvarsson G, Falk ES, et al. Dermatitis herpetiformis and celiac disease are both primarily associated with the HLA-DQ (alpha 1*0501, beta 1*02) or the HLA-DQ (alpha 1*03, beta 1*0302) heterodimers. Tissue Antigens 1997; 49: 29\u201334.","journal-title":"Tissue Antigens"},{"key":"3533_CR17","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1097\/DAD.0000000000000420","volume":"38","author":"MA Barnadas","year":"2016","unstructured":"Barnadas MA. Dermatitis herpetiformis: a review of direct immunofluorescence findings. Am J Dermatopathol 2016; 38: 283\u20138.","journal-title":"Am J Dermatopathol"},{"key":"3533_CR18","first-page":"17","volume":"157","author":"SE Clements","year":"2007","unstructured":"Clements SE, Stefanato CM, Groves RW. Atypical dermatitis herpetiformis with fibrillar IgA deposition. Br J Dermatol 2007; 157: 17.","journal-title":"Br J Dermatol"},{"key":"3533_CR19","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1111\/j.1468-3083.2011.04204.x","volume":"26","author":"F Zhang","year":"2012","unstructured":"Zhang F, Yang B, Lin Y, et al. Dermatitis herpetiformis in China: a report of 22 cases. J Eur Acad Dermatol Venereol 2012; 26: 903\u20137.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3533_CR20","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/j.1600-0560.2009.01472.x","volume":"37","author":"CJ Ko","year":"2010","unstructured":"Ko CJ, Colegio OR, Moss JE, et al. Fibrillar IgA deposition in dermatitis herpetiformis-an underreported pattern with potential clinical significance. J Cutan Pathol 2010; 37: 475\u20137.","journal-title":"J Cutan Pathol"},{"key":"3533_CR21","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1001\/archderm.1993.01680250068008","volume":"129","author":"S Kawana","year":"1993","unstructured":"Kawana S, Segawa A. Confocal laser scanning microscopic and immunoelectron microscopic studies of the anatomical distribution of fibrillar IgA deposits in dermatitis herpetiformis. Arch Dermatol 1993; 129: 456\u20139.","journal-title":"Arch Dermatol"},{"key":"3533_CR22","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/1523-1747.ep12664534","volume":"67","author":"H Yaoita","year":"1976","unstructured":"Yaoita H, Katz SI. Immunoelectronmicroscopic localization of IgA in skin of patients with dermatitis herpetiformis. J Invest Dermatol 1976; 67: 502\u20136.","journal-title":"J Invest Dermatol"},{"key":"3533_CR23","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1111\/1523-1747.ep12664537","volume":"67","author":"G Stingl","year":"1976","unstructured":"Stingl G, H\u00f6nigsmann H, Holubar K, et al. Ultrastructural localization of immunoglobulins in skin of patients with dermatitis herpetiformis. J Invest Dermatol 1976; 67: 507\u201312.","journal-title":"J Invest Dermatol"},{"key":"3533_CR24","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1001\/archderm.1990.01670350083014","volume":"126","author":"S K\u00e1rp\u00e1ti","year":"1990","unstructured":"K\u00e1rp\u00e1ti S, Meurer M, Stolz W, et al. Dermatitis herpetiformis bodies. Ultrastructural study on the skin of patients using direct preembedding immunogold labeling. Arch Dermatol 1990; 126: 1469\u201374.","journal-title":"Arch Dermatol"},{"key":"3533_CR25","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/1523-1747.ep12515903","volume":"96","author":"VA Lightner","year":"1991","unstructured":"Lightner VA, Sakai LY, Hall RP. IgA-binding structures in dermatitis herpetiformis skin are independent of elastic-microfibrillar bundles. J Invest Dermatol 1991; 96: 88\u201392.","journal-title":"J Invest Dermatol"},{"key":"3533_CR26","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/1523-1747.ep12481882","volume":"66","author":"G Cotta-Pereira","year":"1976","unstructured":"Cotta-Pereira G, Guerra Rodrigo F, Bittencourt-Sampaio S. Oxytalan, elaunin, and elastic fibers in the human skin. J Invest Dermatol 1976; 66: 143\u20138.","journal-title":"J Invest Dermatol"},{"key":"3533_CR27","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/j.1365-2133.1981.tb01202.x","volume":"105","author":"S Reitamo","year":"1981","unstructured":"Reitamo S, Reunala T, Konttinen YT, et al. Inflammatory cells, IgA, C3, fibrin and fibronectin in skin lesions in dermatitis herpetiformis. Br J Dermatol 1981; 105: 167\u201377.","journal-title":"Br J Dermatol"},{"key":"3533_CR28","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00281-011-0290-8","volume":"34","author":"D Davalos","year":"2012","unstructured":"Davalos D, Akassoglou K. Fibrinogen as a key regulator of inflammation in disease. Semin Immunopathol 2012; 34: 43\u201362.","journal-title":"Semin Immunopathol"},{"key":"3533_CR29","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/jid.2014.368","volume":"135","author":"TB Taylor","year":"2015","unstructured":"Taylor TB, Schmidt LA, Meyer LJ, et al. Transglutaminase 3 present in the IgA aggregates in dermatitis herpetiformis skin is enzymatically active and binds soluble fibrinogen. J Invest Dermatol 2015; 135: 623\u20135.","journal-title":"J Invest Dermatol"},{"key":"3533_CR30","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1111\/jdv.12913","volume":"30","author":"P Bogn\u00e1r","year":"2016","unstructured":"Bogn\u00e1r P, G\u00f6r\u00f6g A, K\u00e1rp\u00e1ti S. High prevalence of cryofibrinogenaemia in dermatitis herpetiformis. J Eur Acad Dermatol Venereol 2016; 30: 517\u20138.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3533_CR31","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jdermsci.2016.07.005","volume":"84","author":"A G\u00f6r\u00f6g","year":"2016","unstructured":"G\u00f6r\u00f6g A, N\u00e9meth K, Szab\u00f3 L, et al. Decreased fibrinolytic potential and morphological changes of fibrin structure in dermatitis herpetiformis. J Dermatol Sci 2016; 84: 17\u201323.","journal-title":"J Dermatol Sci"},{"key":"3533_CR32","doi-asserted-by":"publisher","first-page":"239691","DOI":"10.1155\/2012\/239691","volume":"2012","author":"D Bonciani","year":"2012","unstructured":"Bonciani D, Verdelli A, Bonciolini V, et al. Dermatitis herpetiformis: from the genetics to the development of skin lesions. Clin Dev Immunol 2012; 2012: 239691.","journal-title":"Clin Dev Immunol"},{"key":"3533_CR33","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/1523-1747.ep12479517","volume":"97","author":"DP Kadunce","year":"1991","unstructured":"Kadunce DP, McMurry MP, Avots-Avotins A, et al. The effect of an elemental diet with and without gluten on disease activity in dermatitis herpetiformis. J Invest Dermatol 1991; 97: 175\u201382.","journal-title":"J Invest Dermatol"},{"key":"3533_CR34","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/nm0797-797","volume":"3","author":"W Dieterich","year":"1997","unstructured":"Dieterich W, Ehnis T, Bauer M, et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 1997; 3: 797\u2013801.","journal-title":"Nat Med"},{"key":"3533_CR35","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1084\/jem.20011299","volume":"195","author":"M S\u00e1rdy","year":"2002","unstructured":"S\u00e1rdy M, K\u00e1rp\u00e1ti S, Merkl B, et al. Epidermal transglutaminase (TGase 3) is the autoantigen of dermatitis herpetiformis. J Exp Med 2002; 195: 747\u201357.","journal-title":"J Exp Med"},{"key":"3533_CR36","first-page":"313","volume":"15","author":"K Hitomi","year":"2005","unstructured":"Hitomi K. Transglutaminases in skin epidermis. Eur J Dermatol 2005; 15: 313\u20139.","journal-title":"Eur J Dermatol"},{"key":"3533_CR37","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/jid.2008.231","volume":"129","author":"S Thibaut","year":"2009","unstructured":"Thibaut S, Cavusoglu N, de Becker E, et al. Transglutaminase-3 enzyme: a putative actor in human hair shaft scaffolding? J Invest Dermatol 2009; 129: 449\u201359.","journal-title":"J Invest Dermatol"},{"key":"3533_CR38","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/1476-4598-12-151","volume":"12","author":"X Wu","year":"2013","unstructured":"Wu X, Cao W, Wang X, et al. TGM3, a candidate tumor suppressor gene, contributes to human head and neck cancer. Mol Cancer 2013; 12: 151.","journal-title":"Mol Cancer"},{"key":"3533_CR39","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1002\/(SICI)1521-4141(199908)29:08<2506::AID-IMMU2506>3.0.CO;2-9","volume":"29","author":"H Quarsten","year":"1999","unstructured":"Quarsten H, Molberg O, Fugger L, et al. HLA binding and T cell recognition of a tissue transglutaminase-modified gliadin epitope. Eur J Immunol 1999; 29: 2506\u201314.","journal-title":"Eur J Immunol"},{"key":"3533_CR40","doi-asserted-by":"crossref","first-page":"12682","DOI":"10.1016\/S0021-9258(18)31442-X","volume":"268","author":"IG Kim","year":"1993","unstructured":"Kim IG, Gorman JJ, Park SC, et al. The deduced sequence of the novel protransglutaminase E (TGase3) of human and mouse. J Biol Chem 1993; 268: 12682\u201390.","journal-title":"J Biol Chem"},{"key":"3533_CR41","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.jid.2016.03.039","volume":"136","author":"A G\u00f6r\u00f6g","year":"2016","unstructured":"G\u00f6r\u00f6g A, N\u00e9meth K, Kolev K, et al. Circulating transglutaminase 3-immunoglobulin A immune complexes in dermatitis herpetiformis. J Invest Dermatol 2016; 136: 1729\u201331.","journal-title":"J Invest Dermatol"},{"key":"3533_CR42","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1038\/sj.jid.5700682","volume":"127","author":"MR Donaldson","year":"2007","unstructured":"Donaldson MR, Zone JJ, Schmidt LA, et al. Epidermal transglutaminase deposits in perilesional and uninvolved skin in patients with dermatitis herpetiformis. J Invest Dermatol 2007; 127: 1268\u201371.","journal-title":"J Invest Dermatol"},{"key":"3533_CR43","doi-asserted-by":"publisher","first-page":"4474","DOI":"10.4049\/jimmunol.1003273","volume":"186","author":"JJ Zone","year":"2011","unstructured":"Zone JJ, Schmidt LA, Taylor TB, et al. Dermatitis herpetiformis sera or goat anti-transglutaminase-3 transferred to human skin-grafted mice mimics dermatitis herpetiformis immunopathology. J Immunol 2011; 186: 4474\u201380.","journal-title":"J Immunol"},{"key":"3533_CR44","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1016\/j.jid.2018.03.1497","volume":"138","author":"TB Taylor","year":"2018","unstructured":"Taylor TB, Zone JJ. Sensitivity of transglutaminase 3 in the IgA aggregates in dermatitis herpetiformis skin to potassium iodide. J Invest Dermatol 2018; 138: 2066\u20138.","journal-title":"J Invest Dermatol"},{"key":"3533_CR45","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1111\/j.1365-2133.1994.tb08584.x","volume":"131","author":"JJ Garioch","year":"1994","unstructured":"Garioch JJ, Baker BS, Leonard JN, et al. T lymphocytes in lesional skin of patients with dermatitis herpetiformis. Br J Dermatol 1994; 131: 822\u20136.","journal-title":"Br J Dermatol"},{"key":"3533_CR46","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1159\/000236199","volume":"98","author":"S Romagnani","year":"1992","unstructured":"Romagnani S. Human TH1 and TH2 subsets: regulation of differentiation and role in protection and immunopathology. Int Arch Allergy Immunol 1992; 98: 279\u201385.","journal-title":"Int Arch Allergy Immunol"},{"key":"3533_CR47","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1111\/j.1365-2133.1993.tb00479.x","volume":"129","author":"M Graeber","year":"1993","unstructured":"Graeber M, Baker BS, Garioch JJ, et al. The role of cytokines in the generation of skin lesions in dermatitis herpetiformis. Br J Dermatol 1993; 129: 530\u20132.","journal-title":"Br J Dermatol"},{"key":"3533_CR48","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1046\/j.1365-2133.1998.02068.x","volume":"138","author":"M Caproni","year":"1998","unstructured":"Caproni M, Feliciani C, Fuligni A, et al. Th2-like cytokine activity in dermatitis herpetiformis. Br J Dermatol 1998; 138: 242\u20137.","journal-title":"Br J Dermatol"},{"key":"3533_CR49","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1046\/j.1365-2133.2000.03765.x","volume":"143","author":"P Amerio","year":"2000","unstructured":"Amerio P, Verdolini R, Giangiacomi M, et al. Expression of eotaxin, interleukin 13 and tumour necrosis factor-alpha in dermatitis herpetiformis. Br J Dermatol 2000; 143: 974\u20138.","journal-title":"Br J Dermatol"},{"key":"3533_CR50","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1038\/sj.jid.5700277","volume":"126","author":"RP Hall III","year":"2006","unstructured":"Hall RP 3rd., Takeuchi F, Benbenisty KM, et al. Cutaneous endothelial cell activation in normal skin of patients with dermatitis herpetiformis associated with increased serum levels of IL-8, sE-Selectin and TNF-\u03b1. J Invest Dermatol 2006; 126: 1331\u20137.","journal-title":"J Invest Dermatol"},{"key":"3533_CR51","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s11882-014-0423-y","volume":"14","author":"A Rabenhorst","year":"2014","unstructured":"Rabenhorst A, Hartmann K. Interleukin-31: a novel diagnostic marker of allergic diseases. Curr Allergy Asthma Rep 2014; 14: 423.","journal-title":"Curr Allergy Asthma Rep"},{"key":"3533_CR52","doi-asserted-by":"publisher","first-page":"5965492","DOI":"10.1155\/2017\/5965492","volume":"2017","author":"L Kulczycka-Siennicka","year":"2017","unstructured":"Kulczycka-Siennicka L, Cynkier A, Waszczykowska E, et al. The role of intereukin-31 in pathogenesis of itch and its intensity in a course of Bullous pemphigoid and dermatitis herpetiformis. Biomed Res Int 2017; 2017: 5965492.","journal-title":"Biomed Res Int"}],"container-title":["European Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1684\/ejd.2019.3533.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1684\/ejd.2019.3533\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1684\/ejd.2019.3533.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.jle.com\/10.1684\/ejd.2019.3533","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T11:21:29Z","timestamp":1741173689000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jle.com\/10.1684\/ejd.2019.3533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["3533"],"URL":"https:\/\/doi.org\/10.1684\/ejd.2019.3533","relation":{},"ISSN":["1952-4013"],"issn-type":[{"value":"1952-4013","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"28 September 2018","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 Mai 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}